Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Venture Partners IV Q. Lp Vantagepoint currently holds 57,023 shares of Anthera Pharmaceuticals Inc (ANTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners IV Q. Lp Vantagepoint has been a net seller of ANTH stock. They have purchased $10.5M and sold $126.7M worth of shares.
Venture Partners IV Q. Lp Vantagepoint's most recent insider trade was on May 26, 2015, when they sold 8,937 shares at $0.00 per share.
Venture Partners IV Q. Lp Vantagepoint serves as Executive at Anthera Pharmaceuticals Inc (ANTH). They have executed 32 insider transactions totaling $137.2M over their tenure at the company.
Venture Partners IV Q. Lp Vantagepoint holds the position of Executive at Anthera Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Venture Partners IV Q. Lp Vantagepoint has shown a selling trading pattern, with $10.5M in total purchases and $126.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Venture Partners IV Q. Lp Vantagepoint was on Aug 19, 2013, when they sold $109.9M worth of WAGE shares. This transaction involved 2,718,000 shares at $40.45 per share.
Venture Partners IV Q. Lp Vantagepoint currently owns 57,023 shares of Anthera Pharmaceuticals Inc (ANTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Venture Partners IV Q. Lp Vantagepoint's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Venture Partners IV Q. Lp Vantagepoint has 32 Form 4 filings on record as an insider at Anthera Pharmaceuticals Inc.
Set alerts for Venture Partners IV Q. Lp Vantagepoint and 40,000+ other insiders.